LDN works by transient antagonism of the opioid receptors, thereby tricking the body to upregulate them.
Recently, I started taking a low dose of Clonidine for sleep. Clonidine binds to presynaptic alpha2 receptors, reducing adrenaline release. However, during the day I started having random shivers, I recognized them as adrenaline driven, since I also have them when I take midrodine, a pure alpha1 agonist.
What I think happened is that the low dose of Clonidine slowly reduced the number of alpha2 receptors.
Something similar happens when I took gabapentin for sleep. The following day I started having peripheral neuropathy. Gabapentin is used to treat neuropathy by blocking calcium channels is glutamatergic neurons, so I imagine the body upregulated those channels.
Now the question is, if our bodies are so sensible to neuroactive substances, could we take a low dose of a GABAa and a D2 antagonist in order to induce receptor upregulation? Or is naltrexone somehow special?
Recently, I started taking a low dose of Clonidine for sleep. Clonidine binds to presynaptic alpha2 receptors, reducing adrenaline release. However, during the day I started having random shivers, I recognized them as adrenaline driven, since I also have them when I take midrodine, a pure alpha1 agonist.
What I think happened is that the low dose of Clonidine slowly reduced the number of alpha2 receptors.
Something similar happens when I took gabapentin for sleep. The following day I started having peripheral neuropathy. Gabapentin is used to treat neuropathy by blocking calcium channels is glutamatergic neurons, so I imagine the body upregulated those channels.
Now the question is, if our bodies are so sensible to neuroactive substances, could we take a low dose of a GABAa and a D2 antagonist in order to induce receptor upregulation? Or is naltrexone somehow special?